Assignee
ASTRAZENECA PHARMACEUTICALS LP
US·1 granted patent·18 pending applications·2 citations·filing 2012–2024
Top patents by PatentIndex Score
19 records- 0172US2024325298A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2024·Application pending·0 cites
- 0268US2023026203A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 0365US2024252432A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 0465US2024358662A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 0565US2024252440A1Compositions, methods and systems for aerosol drug deliveryASTRAZENECA PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 0664US2014200183A1Treatment of cardiac arrhythmiasASTRAZENECA PHARMACEUTICALS LP·Filed 2014·Application pending·0 cites
- 0760US10789558B2Non-linear systems and methods for destination selectionASTRAZENECA PHARMACEUTICALS LP·Filed 2018·Granted Sep 29, 2020·2 cites·32 claims
- 0858US2014066368A1Methods For Affecting Body CompositionASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 0957US2013331322A1Exendins and exendin agonist analogs to regulate gastrointestinal motilityASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 1055US2013274182A1Engineered polypeptides having enhanced duration of actionASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 1150US2014056924A1Glp-1 receptor agonist compounds for obstructive sleep apneaASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 1248US2013281374A1Dpp-iv resistant gip hybrid polypeptides with selectable propertiesASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 1348US2014135261A1Peptide yy and peptide yy agonists for treatment of metabolic disordersASTRAZENECA PHARMACEUTICALS LP·Filed 2014·Application pending·0 cites
- 1444US2019276543A1Compositions and methods for treating late stage lung cancerASTRAZENECA PHARMACEUTICALS LP·Filed 2018·Application pending·0 cites
- 1543US2014162943A1N-terminus conformationally constrained glp-1 receptor agonist compoundsASTRAZENECA PHARMACEUTICALS LP·Filed 2014·Application pending·0 cites
- 1636US2020394581A1Non-linear systems and methods for destination selectionASTRAZENECA PHARMACEUTICALS LP·Filed 2020·Application pending·0 cites
- 1736US2017029499A1Methods for treating hepcidin-mediated disordersASTRAZENECA PHARMACEUTICALS LP·Filed 2016·Application pending·0 cites
- 1834US2014249077A1Gel compositionsASTRAZENECA PHARMACEUTICALS LP·Filed 2012·Application pending·0 cites
- 1930US2014221282A1Long duration dual hormone conjugatesASTRAZENECA PHARMACEUTICALS LP·Filed 2012·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →